L3-0206 — Annual report 2009
1.
Development, characterisation and validation of a new generation of monoclonal antibodies for blood grouping

The research group Biomedicine lead by V. Čurin Šerbec) was also engaged in the applicative project for the industrial partner (DiaMed BioRad). A new generation of monoclonal antibodies was developed, characterised and validated to use them in a new format of diagnostic test. The experience of good practice from industrial projects is implemented in the research work of the group.

D.01 Chairing over/coordinating (international and national) projects

2.
Overwiev of potentials for the infection of CHO cell line with prions, Simon Koren and Vladka Čurin Šerbec, Detailed expert report for Lek-Novartis

On the basis of the knowledge, obtained during national research projects and the overwiev of the existing literature, the authors made the analyses of the potentials for the infection of CHO cell line, which is used in biopharmaceutical production, with prions.

D.08 Management and development of research activities